Cynata Therapeutics Valuation
| CYYNF Stock | USD 0.22 0.00 0.00% |
Cynata Therapeutics seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Cynata Therapeutics from analyzing the firm fundamentals such as Current Valuation of 12.47 M, return on equity of -0.21, and Profit Margin of (0.70) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Cynata Therapeutics' price fluctuation is out of control at this time. Calculation of the real value of Cynata Therapeutics is based on 3 months time horizon. Increasing Cynata Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cynata pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Cynata Therapeutics Limited. Since Cynata Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cynata Pink Sheet. However, Cynata Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.22 | Real 0.17 | Hype 0.22 |
The real value of Cynata Pink Sheet, also known as its intrinsic value, is the underlying worth of Cynata Therapeutics Company, which is reflected in its stock price. It is based on Cynata Therapeutics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cynata Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cynata Therapeutics Limited helps investors to forecast how Cynata pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cynata Therapeutics more accurately as focusing exclusively on Cynata Therapeutics' fundamentals will not take into account other important factors: About Cynata Therapeutics Valuation
The pink sheet valuation mechanism determines Cynata Therapeutics' current worth on a weekly basis. Our valuation model uses a comparative analysis of Cynata Therapeutics. We calculate exposure to Cynata Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cynata Therapeutics's related companies.Cynata Therapeutics Limited, together with its subsidiaries, develops and commercializes a proprietary mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia. Cynata Therapeutics Limited was founded in 2011 and is based in Cremorne, Australia. Cynata Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Cynata Therapeutics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Cynata Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cynata Therapeutics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Cynata Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Cynata Therapeutics' revenue streams: Identify Cynata Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Cynata Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Cynata Therapeutics' growth potential: Evaluate Cynata Therapeutics' management, business model, and growth potential.
- Determine Cynata Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cynata Therapeutics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Cynata Therapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Cynata Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 143.3 M | |
| Retained Earnings | -58.3 M |
Complementary Tools for Cynata Pink Sheet analysis
When running Cynata Therapeutics' price analysis, check to measure Cynata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cynata Therapeutics is operating at the current time. Most of Cynata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cynata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cynata Therapeutics' price. Additionally, you may evaluate how the addition of Cynata Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |